Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389030%3A_____%2F25%3A00637220" target="_blank" >RIV/61389030:_____/25:00637220 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68081707:_____/25:00637220 RIV/61989592:15310/25:73632042 RIV/61989592:15110/25:73632042
Výsledek na webu
<a href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00982" target="_blank" >https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00982</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/acs.jmedchem.5c00982" target="_blank" >10.1021/acs.jmedchem.5c00982</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions
Popis výsledku v původním jazyce
Nitro-fatty acids (NO2FAs) are endogenously produced electrophiles and NRF2 activators with therapeutic potential. We developed a synthetic protocol combining a Henry reaction and base-promoted beta-elimination, yielding ultrapure regio/stereoisomers of nitro-stearic (NO2SA), nitro-oleic (NO2OA), and conjugated/bis-allylic nitro-linoleic (NO2LA) acids. These were tested for NRF2 pathway activation in bone marrow cells under different oxygen conditions. We observed that 9- and 10-NO 2 OA, and 10-NO 2 LA increased NRF2 stabilization under hypoxia, while 9- and 10-NO 2 OA significantly upregulated Hmox1 and Gclm at all oxygen levels. 9- and 10-NO 2 OA enhanced HO-1 and GCLM proteins independently of oxygen, while 10-NO 2 LA was oxygen-dependent, boosting HO-1 under hypoxia and GCLM under ambient conditions. Moreover, 10-NO 2 OA and 10-NO 2 LA induced NRF2 nuclear translocation. In contrast, the saturated 10-NO 2 SA, which has lower electron-acceptor ability, was inactive. In summary, these findings suggest the biological activity of NO2FAs is dependent on oxygen level, which could be used in future research of other oxidative stress-dependent pathways.
Název v anglickém jazyce
Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions
Popis výsledku anglicky
Nitro-fatty acids (NO2FAs) are endogenously produced electrophiles and NRF2 activators with therapeutic potential. We developed a synthetic protocol combining a Henry reaction and base-promoted beta-elimination, yielding ultrapure regio/stereoisomers of nitro-stearic (NO2SA), nitro-oleic (NO2OA), and conjugated/bis-allylic nitro-linoleic (NO2LA) acids. These were tested for NRF2 pathway activation in bone marrow cells under different oxygen conditions. We observed that 9- and 10-NO 2 OA, and 10-NO 2 LA increased NRF2 stabilization under hypoxia, while 9- and 10-NO 2 OA significantly upregulated Hmox1 and Gclm at all oxygen levels. 9- and 10-NO 2 OA enhanced HO-1 and GCLM proteins independently of oxygen, while 10-NO 2 LA was oxygen-dependent, boosting HO-1 under hypoxia and GCLM under ambient conditions. Moreover, 10-NO 2 OA and 10-NO 2 LA induced NRF2 nuclear translocation. In contrast, the saturated 10-NO 2 SA, which has lower electron-acceptor ability, was inactive. In summary, these findings suggest the biological activity of NO2FAs is dependent on oxygen level, which could be used in future research of other oxidative stress-dependent pathways.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10611 - Plant sciences, botany
Návaznosti výsledku
Projekt
<a href="/cs/project/GA23-06051S" target="_blank" >GA23-06051S: Elektrofilní nitrované mastné kyseliny jako ochrana proti poškození krvetvorby způsobené ionizujícím zářením: ovlivnění dráhy NRF2</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Medicinal Chemistry
ISSN
0022-2623
e-ISSN
1520-4804
Svazek periodika
68
Číslo periodika v rámci svazku
11
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
13
Strana od-do
12172-12184
Kód UT WoS článku
001497562200001
EID výsledku v databázi Scopus
2-s2.0-105006678085